Nuveen Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $214K | Hold |
28,837
| – | – | ﹤0.01% | 3193 |
|
|
2024
Q3 | $142K | Hold |
28,837
| – | – | ﹤0.01% | 3278 |
|
|
2024
Q2 | $148K | Buy |
+28,837
| New | +$148K | ﹤0.01% | 3271 |
|
|
2023
Q1 | – | Sell |
-90,357
| Closed | -$586K | – | 3122 |
|
|
2022
Q4 | $586K | Sell |
90,357
-13,508
| -13% | -$87.6K | ﹤0.01% | 2841 |
|
|
2022
Q3 | $924K | Sell |
103,865
-502
| -0.5% | -$4.47K | ﹤0.01% | 2787 |
|
|
2022
Q2 | $1.04M | Sell |
104,367
-8,042
| -7% | -$80.2K | ﹤0.01% | 2761 |
|
|
2022
Q1 | $1.24M | Sell |
112,409
-1,777
| -2% | -$19.7K | ﹤0.01% | 2723 |
|
|
2021
Q4 | $1.22M | Sell |
114,186
-32,192
| -22% | -$345K | ﹤0.01% | 2786 |
|
|
2021
Q3 | $1.35M | Sell |
146,378
-22,601
| -13% | -$208K | ﹤0.01% | 2856 |
|
|
2021
Q2 | $1.9M | Buy |
168,979
+18,929
| +13% | +$213K | ﹤0.01% | 2739 |
|
|
2021
Q1 | $1.59M | Sell |
150,050
-312,524
| -68% | -$3.31M | ﹤0.01% | 2717 |
|
|
2020
Q4 | $5.02M | Buy |
462,574
+332,295
| +255% | +$3.61M | ﹤0.01% | 2075 |
|
|
2020
Q3 | $1.27M | Buy |
130,279
+16,203
| +14% | +$158K | ﹤0.01% | 2585 |
|
|
2020
Q2 | $908K | Buy |
114,076
+13,064
| +13% | +$104K | ﹤0.01% | 2656 |
|
|
2020
Q1 | $878K | Sell |
101,012
-425
| -0.4% | -$3.69K | ﹤0.01% | 2564 |
|
|
2019
Q4 | $1.15M | Sell |
101,437
-449
| -0.4% | -$5.08K | ﹤0.01% | 2642 |
|
|
2019
Q3 | $1.11M | Buy |
101,886
+2,368
| +2% | +$25.8K | ﹤0.01% | 2658 |
|
|
2019
Q2 | $933K | Buy |
+99,518
| New | +$933K | ﹤0.01% | 2770 |
|